Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 903, pseudogene (RNU6-903P) is a **processed pseudogene** corresponding to a U6 small nuclear RNA (snRNA) locus[3]. U6 snRNA itself is a core non-coding RNA of the spliceosomal complex, involved in pre-mRNA splicing[7]. RNU6-903P, however, **does not code for a functional RNA or protein product and does not participate directly or indirectly in any known molecular or disease mechanism**[1][3][5]. Pseudogenes like RNU6-903P typically represent disabled genomic copies of functional genes and are generally not considered therapeutic targets; they lack protein-coding capacity and do not encode receptor, transporter, enzyme, or other druggable classes[2][3]. There is no evidence that RNU6-903P has any known **biological function, disease association, therapeutic relevance, drug interactions, or recognized biomarker value**[1][2][3][5]. It is not a receptor or any other actionable molecular target for drug development. Assessment of correctness: This entry is **not a receptor, target, nor functional molecule** as used in therapeutic discovery or clinical biomarker applications. Pseudogenes are distinguished from genes by their lack of a functional product. Therefore, RNU6-903P should not be classified as a therapeutic target, nor is it relevant for drug mechanisms or disease pathways in current biomedical knowledge[2][3]. If you require structured data for genomic annotation, you may reference its HGNC ID (HGNC:47867)[3], but do not treat it as a valid target in therapeutic or diagnostic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 903, pseudogene (RNU6-903P).